September 17, 2024
October 31, 2019
Upcoming Events
22nd Annual PEGS Boston
Date: May. 11 – 15, 2026
Venue:
Omni Boston Hotel at the Seaport
450 Summer St, Boston, MA
Booth Number: 41
Join Invenra at PEGS Booth 41 to see how we are delivering therapeutic-quality antibody leads in just 8 weeks with Invenra mAb Discovery Services. Also, discover how the T-Body™ Trispecific Platform and 52 Views of Cancer program are enhancing our perspective and inspiring new possibilities in antibody therapeutics and ADCs.
Podium Presentations
Date/Time: May 11 | 12:10 PM
Track: Emerging T-Cell Engagers
Title: Engineering Trispecific CD3×CD28 T-Cell Engagers: Systematic Optimization of Affinity, Format, and Co-Stimulation
Speaker: Bryan Glaser, PhD, SVP, Business Development, Invenra Inc.
Date/Time: May 14 | 09:50 AM
Track: Engineering Bispecific and Multispecific Antibodies
Title: From Bi- to Trispecific Antibodies: Reimagining the Next Generation of ADCs
Speaker: Bonnie Hammer, PhD, EVP, Research & Development, Invenra Inc.
Poster Presentations
From High-Quality mAb Discovery to Multispecific Therapeutics – Discovered. Designed. Delivered.
Presenter: Bonnie Hammer, EVP- R&D
Location: Poster A061
Enabling Rapid Bispecific Antibody Discovery with Invenra’s B-Body Platform
Presenter: Hongbo Chen, Senior Scientist II
Location: Poster C064
Prior Events
16th World ADC San Diego
Venue:
Town & Country Resort
500 Hotel Circle N
San Diego, CA 92108
Booth Number: 14
Talk, Tuesday Nov 4, 11:30am
Invenra’s Bispecific B-Body Platform and Trispecific T-Body Platform: Versatile Multispecific Systems for Broad-Spectrum ADC Discovery
Speaker: Bonnie Hammer, PhD, EVP, Research & Development, Invenra, Inc.
Poster Presentation
Invenra’s Bispecific B-Body® Platform and Trispecific T-Body™ Platform: Versatile Multispecific Systems for Broad-Spectrum ADC Discovery
Antibody Engineering & Therapeutics
Venue:
Marriott Marquis San Diego Marina
333 West Harbor Drive
San Diego, 92101
Booth Number: To be announced
Talk:
T-Body: A Novel Trispecific Antibody Platform to Accelerate and De-Risk Drug Discovery
Speaker: Nicholas Marshall, PhD, Head of Protein Sciences, Invenra, Inc.





